Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats

Author： Bunting M.W.   Widdop R.E.  

Publisher： Elsevier

ISSN： 0014-2999

Source： European Journal of Pharmacology, Vol.381, Iss.1, 1999-09, pp. : 13-21

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prevention of cyclosporine A-induced renal vasoconstriction by the endothelin receptor antagonist SB 209670

By Brooks D.P.   Contino L.C.  

European Journal of Pharmacology, Vol. 294, Iss. 2, 1995-12 ,pp. : 571-576

Elsevier

Access to resources Recommend Favorite

Prolonged Anti-Hypertensive Effects of Oral Sitaxsentan, a Selective ETA Endothelin Receptor Antagonist, in Spontaneoulsy Hypertensive Hamsters

By Rubinstein Israel  

Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. : 387-390

Springer Publishing Company

Access to resources Recommend Favorite

Ameliorating effect of an endothelin ET A receptor antagonist on renal function of DOCA-salt hypertensive rats

By Matsumura Y.   Hashimoto N.   Fujita K.   Morimoto S.  

European Journal of Pharmacology, Vol. 319, Iss. 1, 1997-01 ,pp. : 65-69

Elsevier

Access to resources Recommend Favorite

Do prostaglandins modulate renal haemodynamic effects of endothelin-1 in conscious lambs?

By Ebenezar Kumar K.   Sharbaf Fatemah Ghane   Qi Wei   Smith Francine Gabriel  

Canadian Journal of Physiology and Pharmacology, Vol. 88, Iss. 2, 2010-02 ,pp. : 161-167

NRC Research Press

Access to resources Recommend Favorite

Effects of Efonidipine Hydrochloride (NZ-105), a Calcium Antagonist, on Renal Function in Conscious Spontaneously Hypertensive Rats

By Yotsumoto T.   Masuda Y.   Shudo C.   Sugita H.   Yamashita T.   Tanaka S.  

General Pharmacology, Vol. 26, Iss. 2, 1995-03 ,pp. : 333-337

Elsevier

Access to resources Recommend Favorite